BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34527589)

  • 1. The Oncogenic Role of APC/C Activator Protein Cdc20 by an Integrated Pan-Cancer Analysis in Human Tumors.
    Wu F; Sun Y; Chen J; Li H; Yao K; Liu Y; Liu Q; Lu J
    Front Oncol; 2021; 11():721797. PubMed ID: 34527589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The panoramic picture of pepsinogen gene family with pan-cancer.
    Shen S; Li H; Liu J; Sun L; Yuan Y
    Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatical Analysis of Gene Expression Omnibus Database Associates TAF7/CCNB1, TAF7/CCNA2, and GTF2E2/CDC20 Pathways with Glioblastoma Development and Prognosis.
    Yang L; Zeng W; Sun H; Huang F; Yang C; Cai X; Lu Y; Zeng J; Yang K
    World Neurosurg; 2020 Jun; 138():e492-e514. PubMed ID: 32147549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma.
    Dong S; Huang F; Zhang H; Chen Q
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30765611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omics- and Pharmacogenomic Evidence for the Prognostic, Regulatory, and Immune-Related Roles of PBK in a Pan-Cancer Cohort.
    Liu Y; Xiang J; Peng G; Shen C
    Front Mol Biosci; 2021; 8():785370. PubMed ID: 34859058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Cdc20 as a novel cancer therapeutic strategy.
    Wang L; Zhang J; Wan L; Zhou X; Wang Z; Wei W
    Pharmacol Ther; 2015 Jul; 151():141-51. PubMed ID: 25850036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive analysis of CDC20 overexpression in common malignant tumors from multiple organs: its correlation with tumor grade and stage.
    Gayyed MF; El-Maqsoud NM; Tawfiek ER; El Gelany SA; Rahman MF
    Tumour Biol; 2016 Jan; 37(1):749-62. PubMed ID: 26245990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel strategy to block mitotic progression for targeted therapy.
    Chi JJ; Li H; Zhou Z; Izquierdo-Ferrer J; Xue Y; Wavelet CM; Schiltz GE; Zhang B; Cristofanilli M; Lu X; Bahar I; Wan Y
    EBioMedicine; 2019 Nov; 49():40-54. PubMed ID: 31669221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell division cycle proteinising prognostic biomarker of breast cancer.
    Cheng L; Huang YZ; Chen WX; Shi L; Li Z; Zhang X; Dai XY; Wei JF; Ding Q
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32285914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-malarial drug dihydroartemisinin downregulates the expression levels of
    Hao L; Li S; Peng Q; Guo Y; Ji J; Zhang Z; Xue Y; Liu Y; Shi X
    Oncol Lett; 2021 Sep; 22(3):653. PubMed ID: 34386075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
    Yang WX; Pan YY; You CG
    Biomed Res Int; 2019; 2019():1245072. PubMed ID: 31737652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy.
    Alfarsi LH; Ansari RE; Craze ML; Toss MS; Masisi B; Ellis IO; Rakha EA; Green AR
    Breast Cancer Res Treat; 2019 Dec; 178(3):535-544. PubMed ID: 31471836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma.
    Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY
    Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Bub1-Plk1 kinase complex promotes spindle checkpoint signalling through Cdc20 phosphorylation.
    Jia L; Li B; Yu H
    Nat Commun; 2016 Feb; 7():10818. PubMed ID: 26912231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of Cyclin Family Gene Expression in Colon Cancer.
    Li J; Zhou L; Liu Y; Yang L; Jiang D; Li K; Xie S; Wang X; Wang S
    Front Oncol; 2021; 11():674394. PubMed ID: 33996604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APC
    Shi M; Dai WQ; Jia RR; Zhang QH; Wei J; Wang YG; Xiang SH; Liu B; Xu L
    Cancer Lett; 2021 Jan; 496():144-155. PubMed ID: 33039559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased CDC20 expression is associated with development and progression of hepatocellular carcinoma.
    Li J; Gao JZ; Du JL; Huang ZX; Wei LX
    Int J Oncol; 2014 Oct; 45(4):1547-55. PubMed ID: 25069850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Expression Levels of CDK1 and CDC20 in Patients With Lung Squamous Cell Carcinoma are Associated With Worse Prognosis.
    Deng H; Hang Q; Shen D; Ying H; Zhang Y; Qian X; Chen M
    Front Mol Biosci; 2021; 8():653805. PubMed ID: 34307447
    [No Abstract]   [Full Text] [Related]  

  • 19. High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma.
    Moura IM; Delgado ML; Silva PM; Lopes CA; do Amaral JB; Monteiro LS; Bousbaa H
    J Oral Pathol Med; 2014 Mar; 43(3):225-31. PubMed ID: 24044615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Integrative Human Pan-Cancer Analysis of Cyclin-Dependent Kinase 1 (CDK1).
    Liu X; Wu H; Liu Z
    Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.